Barry E. Greene - 11 Aug 2022 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
Director
Signature
/s/Nancy Smith, Attorney-in-Fact for Barry Greene
Issuer symbol
KPTI
Transactions as of
11 Aug 2022
Net transactions value
+$11,250
Form type
4
Filing time
15 Aug 2022, 08:05:50 UTC
Previous filing
20 May 2022
Next filing
15 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Options Exercise $11,250 +7,576 +126% $1.48 13,606 11 Aug 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KPTI Stock Option (right to buy) Options Exercise $0 -7,576 -100% $0.000000* 0 11 Aug 2022 Common Stock 7,576 $1.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 14, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter.